Janssen Receives CHMP Positive Opinion For Stelara® (Ustekinumab) Recommending Approval For The Treatment Of Moderately To Severely Active Ulcerative Colitis In The EU
- EMEA Innovative Medicine
- Janssen Receives CHMP Positive Opinion For Stelara® (Ustekinumab) Recommending Approval For The Treatment Of Moderately To Severely Active Ulcerative Colitis In The EU
Janssen Receives CHMP Positive Opinion For Stelara® (Ustekinumab) Recommending Approval For The Treatment Of Moderately To Severely Active Ulcerative Colitis In The EU
- X (Twitter)
Copy link